TW200638942A - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
TW200638942A
TW200638942A TW095103848A TW95103848A TW200638942A TW 200638942 A TW200638942 A TW 200638942A TW 095103848 A TW095103848 A TW 095103848A TW 95103848 A TW95103848 A TW 95103848A TW 200638942 A TW200638942 A TW 200638942A
Authority
TW
Taiwan
Prior art keywords
therapeutic agent
acyl
action
coa
prevention
Prior art date
Application number
TW095103848A
Other languages
Chinese (zh)
Inventor
Tatsuji Enoki
Yoko Kudo
Katsumi Sugiyama
Hiromu Ohnogi
Hiroaki Sagawa
Ikunoshin Kato
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Publication of TW200638942A publication Critical patent/TW200638942A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

A therapeutic agent or preventive agent for a disease requiring an antifoaming action and/or an acyl-CoA-cholesterol acyl transferase inhibitory action on a cell in treatment or prevention, characterized by comprising as an active ingredient, a processed matter derived from Peucedanum japonicum Thunb.
TW095103848A 2005-02-04 2006-02-03 Therapeutic agent TW200638942A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005029596 2005-02-04

Publications (1)

Publication Number Publication Date
TW200638942A true TW200638942A (en) 2006-11-16

Family

ID=36777131

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095103848A TW200638942A (en) 2005-02-04 2006-02-03 Therapeutic agent

Country Status (5)

Country Link
JP (1) JPWO2006082743A1 (en)
KR (1) KR20070100829A (en)
CN (1) CN101115491A (en)
TW (1) TW200638942A (en)
WO (1) WO2006082743A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008015950A1 (en) * 2006-08-02 2008-02-07 Takara Bio Inc. Acat inhibitor
JP5563824B2 (en) * 2007-10-24 2014-07-30 サントリーホールディングス株式会社 Peroxisome proliferator-responsive receptor (PPAR) ligand agent
JP4608017B1 (en) * 2010-03-09 2011-01-05 株式会社資生堂 Pore reducing agent for oral consumption
US20140037762A1 (en) * 2011-02-14 2014-02-06 Toshinori ITOU Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
JP5666053B1 (en) * 2014-08-01 2015-02-12 株式会社 資生堂 Longevity gene expression enhancer
JP7444375B2 (en) 2019-12-28 2024-03-06 株式会社 沖縄リサーチセンター Composition for improving lower urinary tract symptoms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60260515A (en) * 1984-06-07 1985-12-23 Takagi Koichi Pharmaceutical composition containing seselin compound as active component
JPS60260520A (en) * 1984-06-07 1985-12-23 Takagi Koichi Drug composition
EP1623704A4 (en) * 2003-05-02 2009-04-01 Takara Bio Inc Therapeutic agent
TW200539862A (en) * 2004-02-06 2005-12-16 Takara Bio Inc Remedy agent

Also Published As

Publication number Publication date
JPWO2006082743A1 (en) 2008-06-26
KR20070100829A (en) 2007-10-11
WO2006082743A1 (en) 2006-08-10
CN101115491A (en) 2008-01-30

Similar Documents

Publication Publication Date Title
TW200637522A (en) Skin treatment articles and methods
HUS1900037I1 (en) Oral antimicrobial pharmaceutical compositions
TNSN08079A1 (en) Pharmaceutical compositions for the treatment of inner ear disorders
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
EP2023926A4 (en) Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
MY145074A (en) Thiazolidin-4-one derivatives
TW200638942A (en) Therapeutic agent
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
MX339116B (en) Tuberous sclerosis treatment.
WO2009031606A1 (en) Therapeutic and prophylactic agents for arthritis
MY162076A (en) Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
WO2009078447A1 (en) Anti-norovirus agent, anti-influenza-virus agent, and anti-viral treatment method using each of the agents
WO2007077203A3 (en) Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
TNSN07240A1 (en) Compounds for flaviviridae treatment
WO2004028475A3 (en) Glycosylceramide analogues
HK1121936A1 (en) Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
WO2008029237A3 (en) Combination therapies for rheumatoid arthritis
WO2008097364A3 (en) Use of oritavancin for prevention and treatment of anthrax
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
WO2004087045A3 (en) Devices, methods, and compositions to prevent restenosis
WO2008009802A3 (en) Drugs comprising an inhibitor of class 1 alpha mannosidase for the treatment of sarcoglycanopathies
EP1866329A4 (en) Peptides for inhibiting transglutaminase